Richard N. Merchant

Dr. Richard N. Merchant


Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2018 in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Verified
Journal Article
Open access
PDF file
ALAaron Lau
Aaron Lau
NLNasim Lowlaavar
Nasim Lowlaavar
ECErin M. Cooke
Erin M. Cooke
NWNicholas West
Nicholas West
AGAlexandra German
Alexandra German
RMRichard N. Merchant
Richard N. Merchant
The purpose of this study was to evaluate the effects of preoperative forced-air warming on intraoperative hypothermia.

1 December 1990 in Anesthesiology
Verified
Journal Article
Closed access
WNWarren R. Nielson
Warren R. Nielson
AGAdrian W. Gelb
Adrian W. Gelb
JCJoseph E. Casey
Joseph E. Casey
FPFoster J. Penny
Foster J. Penny
RMRichard N. Merchant
Richard N. Merchant
PMPirjo H. Manninen
Pirjo H. Manninen
This study compared the effects of general and regional anesthesia on cognitive and psychosocial functioning in elderly persons. Sixty-four patients between 60 and 86 yr of age undergoing knee arthroplasty were randomly assigned to receive either general or regional anesthesia. A battery of psychometric tests, including the Satz-Mogel form of the Wechsler Adult Intelligence Scale-Revised, the Wechsler Memory Scale-Revised and the Sickness Impact Profile, and various neuropsychological measures were administered by a blinded observer just before surgery and again 3 months later. Analyses of covariance revealed improvements in most measures that were equivalent between groups. The results indicated that there were no cognitive or psychosocial effects of general or regional anesthesia after 3 months in elderly persons undergoing knee arthroplasty. In this patient population, general anesthesia poses no more risk to long-term mental function than regional anesthesia.

1 October 2018 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
NWNicholas West
Nicholas West
KHKlaske van Heusden
Klaske van Heusden
Matthias GörgesMatthias Görges
Matthias Görges
SBSonia Brodie
Sonia Brodie
ARAryannah Rollinson
Aryannah Rollinson
RMRichard N. Merchant
Richard N. Merchant
BACKGROUND: Closed-loop control of anesthesia involves continual adjustment of drug infusion rates according to measured clinical effect. The NeuroSENSE monitor provides an electroencephalographic measure of depth of hypnosis (wavelet-based anesthetic value for central nervous system monitoring [WAVCNS]). It has previously been used as feedback for closed-loop control of propofol, in a system designed using robust control engineering principles, which implements features specifically designed to ensure patient safety. Closed-loop control of a second drug, remifentanil, may be added to improve WAVCNSstability in the presence of variable surgical stimulation. The objective of this study was to design and evaluate the feasibility of a closed-loop system for robust control of propofol and remifentanil infusions using WAVCNSfeedback, with an infusion safety system based on the known pharmacological characteristics of these 2 drugs.METHODS: With Health Canada authorization, research ethics board approval, and informed consent, American Society of Anesthesiologists I–III adults, requiring general anesthesia for elective surgery, were enrolled in a 2-phase study. In both phases, infusion of propofol was controlled in closed loop during induction and maintenance of anesthesia, using WAVCNSfeedback, but bounded by upper- and lower-estimated effect-site concentration limits. In phase I, remifentanil was administered using an adjustable target-controlled infusion and a controller was designed based on the collected data. In phase II, remifentanil was automatically titrated to counteract rapid increases in WAVCNS.RESULTS: Data were analyzed for 127 patients, of median (range) age 64 (22–86) years, undergoing surgical procedures lasting 105 (9–348) minutes, with 52 participating in phase I and 75 in phase II. The overall control performance indicator, global score, was a median (interquartile range) 18.3 (14.2–27.7) in phase I and 14.6 (11.6–20.7) in phase II (median difference, −3.25; 95% confidence interval, −6.35 to −0.52). The WAVCNSwas within ±10 of the setpoint for 84.3% (76.6–90.6) of the maintenance of anesthesia in phase I and 88.2% (83.1–93.4) in phase II (median difference, 3.7; 95% confidence interval, 0.1–6.9). The lower propofol safety bound was activated during 30 of 52 (58%) cases in phase I and 51 of 75 (68%) cases in phase II.CONCLUSIONS: Adding closed-loop control of remifentanil improved overall controller performance. This controller design offers a robust method to optimize the control of 2 drugs using a single sensor. The infusion safety system is an important component of a robust automated anesthesia system, but further research is required to determine the optimal constraints for these safe conditions.

1 May 1992 in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Verified
Journal Article
Closed access
PDF file
PDPeter G. Duncan
Peter G. Duncan
MCMarsha M. Cohen
Marsha M. Cohen
WTW. Arnold Tweed
W. Arnold Tweed
DBDiane Biehl
Diane Biehl
WPWilliam D. B. Pope
William D. B. Pope
DDDon DeBoer
Don DeBoer

1 September 2013 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
KLK Leslie
K Leslie
PMP Myles
P Myles
PDPhilip J Devereaux
Philip J Devereaux
EWE Williamson
E Williamson
PRP Rao-Melancini
P Rao-Melancini
HYH Yang
H Yang
This post hoc analysis aimed to determine whether neuraxial block was associated with a composite of cardiovascular death, non-fatal myocardial infarction (MI) and non-fatal cardiac arrest within 30 days of randomization in POISE trial patients. A total of 8351 non-cardiac surgical patients at high risk of cardiovascular complications were randomized to -blocker or placebo. Neuraxial block was defined as spinal, lumbar or thoracic epidural anaesthesia. Logistic regression, with weighting using estimated propensity scores, was used to determine the association between neuraxial block and primary and secondary outcomes. Neuraxial block was associated with an increased risk of the primary outcome [287 (7.3) vs 229 (5.7); odds ratio (OR), 1.24; 95 confidence interval (CI), 1.021.49; P0.03] and MI [230 (5.9) vs 177 (4.4); OR, 1.32; 95 CI, 1.071.64; P0.009] but not stroke [23 (0.6) vs 32 (0.8); OR, 0.76; 95 CI, 0.441.33; P0.34], death [96 (2.5) vs 111 (2.8); OR, 0.87; 95 CI, 0.651.17; P0.37] or clinically significant hypotension [522 (13.4) vs 484 (12.1); OR, 1.13; 95 CI, 0.991.30; P0.08]. Thoracic epidural with general anaesthesia was associated with a worse primary outcome than general anaesthesia alone [86 (12.1) vs 119 (5.4); OR, 2.95; 95 CI, 2.004.35; P0.001]. In patients at high risk of cardiovascular morbidity, neuraxial block was associated with an increased risk of adverse cardiovascular outcomes, which could be causal or because of residual confounding.

1 May 1992 in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Verified
Journal Article
Closed access
PDF file
MCMarsha M. Cohen
Marsha M. Cohen
PDPeter G. Duncan
Peter G. Duncan
WPWilliam D. B. Pope
William D. B. Pope
DBDiane Biehl
Diane Biehl
WTW. Arnold Tweed
W. Arnold Tweed
RMRichard N. Merchant
Richard N. Merchant